Back
Editas Medicine Stock Price Chart

Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
18
EDIT
Editas Medicine
Last Price:
$1.39
Seasonality Move:
7.98%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is moderately bearish and EDIT is experiencing selling pressure, which indicates risk of future bearish movement.
Editas Medicine Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.43 | Sell |
20-day SMA: | 1.48 | Sell |
50-day SMA: | 1.4 | Sell |
200-day SMA: | 2.41 | Sell |
8-day EMA: | 1.46 | Sell |
20-day EMA: | 1.42 | Sell |
50-day EMA: | 1.1 | Buy |
200-day EMA: | 0.44 | Buy |
Editas Medicine Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 47 | Sell |
Chaikin Money Flow: | -1172138 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.29 - 1.59) | Sell |
Bollinger Bands (100): | (1.13 - 1.69) | Sell |
Editas Medicine Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Editas Medicine Stock
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.38 while EDIT 8-day simple moving average is 1.43, which is a Sell signal.
-
The stock price of EDIT is 1.38 while Editas Medicine 20-day SMA is 1.48, which makes it a Sell.
-
Editas Medicine 50-day simple moving average is 1.40 while EDIT share price is 1.38, making it a Sell technically.
-
EDIT stock price is 1.38 and Editas Medicine 200-day simple moving average is 2.41, creating a Sell signal.
EDIT Technical Analysis vs Fundamental Analysis
Sell
18
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy or a Sell?
-
Editas Medicine stock is rated a SellThe current Editas Medicine [EDIT] share price is $1.38. The Score for EDIT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Editas Medicine Stock Info
Market Cap:
115.5M
Price in USD:
1.38
Share Volume:
1.9M
Editas Medicine 52-Week Range
52-Week High:
6.69
52-Week Low:
0.91
Sell
18
Editas Medicine (EDIT)
is a Sell
Editas Medicine Share Price Forecast
-
What is the Editas Medicine stock price today?The Editas Medicine stock price is 1.38 USD today.
-
Will EDIT stock go up or go down?Editas Medicine> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine is overvalued.
Is Editas Medicine Stock a Buy?
-
Editas Medicine share price is 1.38 while EDIT 8-day exponential moving average is 1.46, which is a Sell signal.
-
The stock price of EDIT is 1.38 while Editas Medicine 20-day EMA is 1.42, which makes it a Sell.
-
Editas Medicine 50-day exponential moving average is 1.10 while EDIT share price is 1.38, making it a Buy technically.
-
EDIT stock price is 1.38 and Editas Medicine 200-day simple moving average is 0.44, creating a Buy signal.
Fundamental Analysis of Editas Medicine
Is Editas Medicine a good investment?
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.07 per share, an increase this year of $0.85 per share, and an increase next year of $0.63 per share.
Technical Analysis of Editas Medicine
Should I short Editas Medicine stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting Editas Medicine is a Buy
-
Editas Medicine Relative Strength Index (RSI) is 47, which suggest Editas Medicine is oversold
-
The Bollinger Bands (25) for Editas Medicine is (1.29 - 1.59), which suggest Editas Medicine is a Sell
-
The Bollinger Bands (100) for Editas Medicine is (1.13 - 1.69), which suggest Editas Medicine is a Sell
* Editas Medicine stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.